Cargando…

Differential functions of RhoGDIβ in malignant transformation and progression of urothelial cell following N-butyl-N-(4-hydmoxybutyl) nitrosamine exposure

BACKGROUND: Functional role of Rho GDP-dissociation inhibitor beta (RhoGDIβ) in tumor biology appears to be contradictory across various studies. Thus, the exploration of the molecular mechanisms underlying the differential functions of this protein in urinary bladder carcinogenesis is highly signif...

Descripción completa

Detalles Bibliográficos
Autores principales: Hua, Xiaohui, Zou, Ronghao, Bai, Xiaoyue, Yang, Yuyao, Lu, Juan, Huang, Chuanshu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463823/
https://www.ncbi.nlm.nih.gov/pubmed/37635218
http://dx.doi.org/10.1186/s12915-023-01683-2
_version_ 1785098322213601280
author Hua, Xiaohui
Zou, Ronghao
Bai, Xiaoyue
Yang, Yuyao
Lu, Juan
Huang, Chuanshu
author_facet Hua, Xiaohui
Zou, Ronghao
Bai, Xiaoyue
Yang, Yuyao
Lu, Juan
Huang, Chuanshu
author_sort Hua, Xiaohui
collection PubMed
description BACKGROUND: Functional role of Rho GDP-dissociation inhibitor beta (RhoGDIβ) in tumor biology appears to be contradictory across various studies. Thus, the exploration of the molecular mechanisms underlying the differential functions of this protein in urinary bladder carcinogenesis is highly significant in the field. Here, RhoGDIβ expression patterns, biological functions, and mechanisms leading to transformation and progression of human urothelial cells (UROtsa cells) were evaluated following varying lengths of exposure to the bladder carcinogen N-butyl-N-(4-hydmoxybutyl) nitrosamine (BBN). RESULTS: It was seen that compared to expression in vehicle-treated control cells, RhoGDIβ protein expression was downregulated after 2-month of BBN exposure, but upregulated after 6-month of exposure. Assessments of cell function showed that RhoGDIβ inhibited UROtsa cell growth in cells with BBN for 2-month exposure, whereas it promoted the invasion of cells treated with BBN for 6 months. Mechanistic studies revealed that 2-month of BBN exposure markedly attenuated DNMT3a abundance, and this led to reduced miR-219a promoter methylation, increased miR-219a binding to the RhoGDIβ mRNA 3’UTR, and reduced RhoGDIβ protein translation. While after 6-mo of BBN treatment, the cells showed increased PP2A/JNK/C-Jun axis phosphorylation and this in turn mediated overall RhoGDIβ mRNA transcription and protein expression as well as invasion. CONCLUSIONS: These findings indicate that RhoGDIβ is likely to inhibit the transformation of human urothelial cells during the early phase of BBN exposure, whereas it promotes invasion of the transformed/progressed urothelial cells in the late stage of BBN exposure. The studies also suggest that RhoGDIβ may be a useful biomarker for evaluating the progression of human bladder cancers. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12915-023-01683-2.
format Online
Article
Text
id pubmed-10463823
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-104638232023-08-30 Differential functions of RhoGDIβ in malignant transformation and progression of urothelial cell following N-butyl-N-(4-hydmoxybutyl) nitrosamine exposure Hua, Xiaohui Zou, Ronghao Bai, Xiaoyue Yang, Yuyao Lu, Juan Huang, Chuanshu BMC Biol Research Article BACKGROUND: Functional role of Rho GDP-dissociation inhibitor beta (RhoGDIβ) in tumor biology appears to be contradictory across various studies. Thus, the exploration of the molecular mechanisms underlying the differential functions of this protein in urinary bladder carcinogenesis is highly significant in the field. Here, RhoGDIβ expression patterns, biological functions, and mechanisms leading to transformation and progression of human urothelial cells (UROtsa cells) were evaluated following varying lengths of exposure to the bladder carcinogen N-butyl-N-(4-hydmoxybutyl) nitrosamine (BBN). RESULTS: It was seen that compared to expression in vehicle-treated control cells, RhoGDIβ protein expression was downregulated after 2-month of BBN exposure, but upregulated after 6-month of exposure. Assessments of cell function showed that RhoGDIβ inhibited UROtsa cell growth in cells with BBN for 2-month exposure, whereas it promoted the invasion of cells treated with BBN for 6 months. Mechanistic studies revealed that 2-month of BBN exposure markedly attenuated DNMT3a abundance, and this led to reduced miR-219a promoter methylation, increased miR-219a binding to the RhoGDIβ mRNA 3’UTR, and reduced RhoGDIβ protein translation. While after 6-mo of BBN treatment, the cells showed increased PP2A/JNK/C-Jun axis phosphorylation and this in turn mediated overall RhoGDIβ mRNA transcription and protein expression as well as invasion. CONCLUSIONS: These findings indicate that RhoGDIβ is likely to inhibit the transformation of human urothelial cells during the early phase of BBN exposure, whereas it promotes invasion of the transformed/progressed urothelial cells in the late stage of BBN exposure. The studies also suggest that RhoGDIβ may be a useful biomarker for evaluating the progression of human bladder cancers. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12915-023-01683-2. BioMed Central 2023-08-28 /pmc/articles/PMC10463823/ /pubmed/37635218 http://dx.doi.org/10.1186/s12915-023-01683-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Hua, Xiaohui
Zou, Ronghao
Bai, Xiaoyue
Yang, Yuyao
Lu, Juan
Huang, Chuanshu
Differential functions of RhoGDIβ in malignant transformation and progression of urothelial cell following N-butyl-N-(4-hydmoxybutyl) nitrosamine exposure
title Differential functions of RhoGDIβ in malignant transformation and progression of urothelial cell following N-butyl-N-(4-hydmoxybutyl) nitrosamine exposure
title_full Differential functions of RhoGDIβ in malignant transformation and progression of urothelial cell following N-butyl-N-(4-hydmoxybutyl) nitrosamine exposure
title_fullStr Differential functions of RhoGDIβ in malignant transformation and progression of urothelial cell following N-butyl-N-(4-hydmoxybutyl) nitrosamine exposure
title_full_unstemmed Differential functions of RhoGDIβ in malignant transformation and progression of urothelial cell following N-butyl-N-(4-hydmoxybutyl) nitrosamine exposure
title_short Differential functions of RhoGDIβ in malignant transformation and progression of urothelial cell following N-butyl-N-(4-hydmoxybutyl) nitrosamine exposure
title_sort differential functions of rhogdiβ in malignant transformation and progression of urothelial cell following n-butyl-n-(4-hydmoxybutyl) nitrosamine exposure
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463823/
https://www.ncbi.nlm.nih.gov/pubmed/37635218
http://dx.doi.org/10.1186/s12915-023-01683-2
work_keys_str_mv AT huaxiaohui differentialfunctionsofrhogdibinmalignanttransformationandprogressionofurothelialcellfollowingnbutyln4hydmoxybutylnitrosamineexposure
AT zouronghao differentialfunctionsofrhogdibinmalignanttransformationandprogressionofurothelialcellfollowingnbutyln4hydmoxybutylnitrosamineexposure
AT baixiaoyue differentialfunctionsofrhogdibinmalignanttransformationandprogressionofurothelialcellfollowingnbutyln4hydmoxybutylnitrosamineexposure
AT yangyuyao differentialfunctionsofrhogdibinmalignanttransformationandprogressionofurothelialcellfollowingnbutyln4hydmoxybutylnitrosamineexposure
AT lujuan differentialfunctionsofrhogdibinmalignanttransformationandprogressionofurothelialcellfollowingnbutyln4hydmoxybutylnitrosamineexposure
AT huangchuanshu differentialfunctionsofrhogdibinmalignanttransformationandprogressionofurothelialcellfollowingnbutyln4hydmoxybutylnitrosamineexposure